Effects Carnitine in Isolated Adipocytes & Myocytes
Effects Carnitine in Isolated Adipocytes & Myocytes
批准号:
6814604
负责人:
Marc Roy Blackman
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
adipocytes apoptosis bioenergetics carnitine cell differentiation cell growth regulation dexamethasone enzyme linked immunosorbent assay exocytosis gene expression glucose metabolism human tissue lipid metabolism microarray technology mitochondrial DNA muscle cells polymerase chain reaction radioimmunoassay sarcopenia tissue /cell culture western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In addition to storing and releasing lipids, adipocytes influence the metabolism of other tissues via an intricate network of secretory factors, such as the adipokines, leptin and adiponectin and the proinflammatory cytokine, IL-6. Leptin, released in response to increased fat storage, is a potent appetite suppressant. Adiponectin induces fat degradation and is protective against atherosclerosis and insulin resistance. IL-6 promotes neolipogenesis by stimulating adipocyte glucose uptake, and adversely affects insulin sensitivity by inhibiting hepatic gluconeogenesis. Obesity is associated with increased leptin and IL-6, and decreased adiponectin.
Carnitine (CAR) is an essential nutrient. It plays a pivotal role in cellular energy metabolism, transferring free fatty acids to mitochondria, followed by their oxidation in the Krebs cycle. CAR is essential for cellular energy production and storage, and for membrane synthesis and repair. L-CAR is an essential cofactor of fatty acid (FA) metabolism. Dietary intake accounts for more than 75% of the average normal daily requirement of LCAR (2-4 mg/kg). Data from animal and human studies suggest that LCAR can modulate abdominal fat content, stimulate weight loss and improve glucose disposal. LCAR is highly marketed in the US as a "fat burner" nutritional supplement and is promoted as an adjunct to weight loss programs. Despite this evidence, the cellular and molecular mechanisms of these apparent effects are not entirely understood. We are evaluating whether these metabolic actions of CAR are mediated, at least in part, via direct effects on adipokine release and lipolytic activity iby isolated human adipocytes derived from subcutaneous fat from nonobese healthy donors. To date, we have observed that L-CAR elicits secretion of adiponectin and leptin, without influencing that of IL-6.
CAR also exerts important anabolic and antioxidant-antiapoptotic effects. Acetyl L-CAR prevents mitochondrial oxidative decay and dysfunction, thus potentially retarding age-associated neurodegenerative symptoms such as memory loss. Activation of the AMPK and Carnitine Palmitoyl Transferase-1 (CPT-I) prevents FA induced ceramide synthesis and ERK mediated apoptosis, while the interactions of CPT-I with cytoskeletal components and with BCL-2 in the mitochondrial outer membrane are thought to contribute to the regulation of cell growth and apoptosis. Acetyl L-CAR administration to HIV patients increases serum IGF-1 concentrations, suggesting anabolic effects. We are investigating the effects of L-CAR using cDNA microarrays, including both a mitochondrion-focused chip and a 12K human chip, aiming to identify new target genes related to lipid and glucose metabolism, mitochondrial biogenesis, cell growth and apoptosis. We are also evaluating the potential role of L-CAR as an anabolic-antiapoptotic agent in human myocytes, and it's effects in human models of sarcopenia due to aging, glucocorticoid excess, and HIV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SCREENING FOR GROWTH HORMONE AND SEX STEROID EFFECTS
-
批准号:6121409
-
项目类别:
-
资助金额:$6.52万
-
财政年份:1998
-
负责人:Marc Roy Blackman
-
依托单位:
PHARMACOKINETIC & SAFETY EVALUATION OF RECOMBINANT HUMAN PROLACTIN
-
批准号:6265724
-
项目类别:
-
资助金额:$6.52万
-
财政年份:1998
-
负责人:Marc Roy Blackman
-
依托单位:
GROWTH HORMONE AND SEX STEROID EFFECTS ON SKELETAL MUSCLE IN OLDER WOMEND & MEN
-
批准号:6281934
-
项目类别:
-
资助金额:$5.69万
-
财政年份:1998
-
负责人:Marc Roy Blackman
-
依托单位:
GROWTH HORMONE AND SEX STEROID EFFECTS ON SKELETAL MUSCLE IN OLDER WOMEND & MEN
-
批准号:6121394
-
项目类别:
-
资助金额:$6.52万
-
财政年份:1998
-
负责人:Marc Roy Blackman
-
依托单位:
SCREENING FOR GROWTH HORMONE AND SEX STEROID EFFECTS
-
批准号:6281949
-
项目类别:
-
资助金额:$5.69万
-
财政年份:1998
-
负责人:Marc Roy Blackman
-
依托单位:
GROWTH HORMONE AND SEX STEROID EFFECTS ON SKELETAL MUSCLE IN OLDER WOMEND & MEN
-
批准号:6252492
-
项目类别:
-
资助金额:$11.34万
-
财政年份:1997
-
负责人:Marc Roy Blackman
-
依托单位:
GROWTH HORMONE & SEX STEROID EFFECTS ON SKELETAL MUSCLE
-
批准号:2052218
-
项目类别:
-
资助金额:$29.3万
-
财政年份:1992
-
负责人:Marc Roy Blackman
-
依托单位:
GROWTH HORMONE & SEX STEROID EFFECTS ON SKELETAL MUSCLE
-
批准号:2052216
-
项目类别:
-
资助金额:$28.05万
-
财政年份:1992
-
负责人:Marc Roy Blackman
-
依托单位:
GROWTH HORMONE & SEX STEROID EFFECTS ON SKELETAL MUSCLE
-
批准号:2052219
-
项目类别:
-
资助金额:$23.37万
-
财政年份:1992
-
负责人:Marc Roy Blackman
-
依托单位:
GROWTH HORMONE & SEX STEROID EFFECTS ON SKELETAL MUSCLE
-
批准号:3122978
-
项目类别:
-
资助金额:$26.0万
-
财政年份:1992
-
负责人:Marc Roy Blackman
-
依托单位:
GROWTH HORMONE & SEX STEROID EFFECTS ON SKELETAL MUSCLE
-
批准号:3122979
-
项目类别:
-
资助金额:$28.03万
-
财政年份:1992
-
负责人:Marc Roy Blackman
-
依托单位:
Male Neuroendocrinology: Chronic Pain/Morphine/Placebo
-
批准号:6959525
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Marc Roy Blackman
-
依托单位:--
Effects of Chronic Pain, Morphine, and Placebo
-
批准号:7129539
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Marc Roy Blackman
-
依托单位:--
GFR AND RPF DURING THE MENSTRUAL CYCLE
-
批准号:5224372
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Marc Roy Blackman
-
依托单位:--
Effects of Chronic Pain, Morphine, and Placebo on Neuroe
-
批准号:7296839
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Marc Roy Blackman
-
依托单位:--
The Effects Of CAM Biological Agents In Human Prostate Cells In Vitro
-
批准号:7592497
-
项目类别:
-
资助金额:$40.0万
-
财政年份:--
-
负责人:Marc Roy Blackman
-
依托单位:--
SCREENING FOR GROWTH HORMONE AND SEX STEROID EFFECTS
-
批准号:6309413
-
项目类别:
-
资助金额:$6.52万
-
财政年份:--
-
负责人:Marc Roy Blackman
-
依托单位:
PHARMACOKINETIC & SAFETY EVALUATION OF RECOMBINANT HUMAN PROLACTIN
-
批准号:6309395
-
项目类别:
-
资助金额:$6.52万
-
财政年份:--
-
负责人:Marc Roy Blackman
-
依托单位:
MAOA/H202 regulation by Dexamethasone & other Steroids i
-
批准号:7296838
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Marc Roy Blackman
-
依托单位:--
Suppression of the GH/IGF-I Axis In Women With Rheumatoi
-
批准号:7296810
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Marc Roy Blackman
-
依托单位:--
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: